Try our Advanced Search for more refined results
IPR
Final Written Decision
Nalox-1 Pharmaceuticals, LLC
Opiant Pharmaceuticals, Inc.
1600
Filed: February 19, 2019 00:00
The Patent Trial and Appeal Board has refused to invalidate three different patents covering Adapt Pharma Ltd.'s opioid overdose treatment Narcan, two of which had a different fate in district court.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login